Kun‐Tu Yeh

4.7k citations

151 papers · 3.7k indexed · h-index 35

Impact in

Endocrine and Autonomic Systems top 1%
- Circadian rhythm and melatonin
Aging top 2%
- Genetics, Aging, and Longevity in Model Organisms

Papers in ⓘ

Molecular Biology 92
- Cancer-related gene regulation 22
- Epigenetics and DNA Methylation 15
- RNA modifications and cancer 14
- Glycosylation and Glycoproteins Research 10
Oncology 34
- Cancer-related Molecular Pathways 10

Co-authors: Jan‐Gowth Chang (47 shared papers)Ya‐Sian Chang (20 shared papers)Ming‐Feng Hou (6 shared papers)Shou‐Jen Kuo (3 shared papers)Shou‐Tung Chen (3 shared papers)Kong‐Bung Choo (2 shared papers)Yueh‐Min Lin (14 shared papers)Jui‐Chang Chen (7 shared papers)
Journals: Clinica Chimica Acta (5 papers)Medical Oncology (4 papers)International Journal of Molecular Sciences (4 papers)PLoS ONE (4 papers)Scientific Reports (3 papers)
Partner nations: Taiwan United States Singapore

In The Last Decade

Kun‐Tu Yeh

149 papers receiving 3.7k citations

Peers

Countries citing papers authored by Kun‐Tu Yeh

Since Specialization

Citations

This map shows the geographic impact of Kun‐Tu Yeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun‐Tu Yeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun‐Tu Yeh more than expected).

Fields of papers citing papers by Kun‐Tu Yeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun‐Tu Yeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun‐Tu Yeh. The network helps show where Kun‐Tu Yeh may publish in the future.

Co-authors

The 25 scholars most cited alongside Kun‐Tu Yeh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kun‐Tu Yeh Line = papers co-authored together Kun‐Tu Yeh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Deregulated expression of the PER1 , PER2 and PER3 genes in breast cancers Carcinogenesis ·Shou‐Tung Chen, Kong‐Bung Choo, Ming‐Feng Hou, Kun‐Tu Yeh, Shou‐Jen Kuo, Jan‐Gowth Chang	2005	337
2	Disturbance of circadian gene expression in hepatocellular carcinoma Molecular Carcinogenesis ·Yueh‐Min Lin, Julia Huei‐Mei Chang, Kun‐Tu Yeh, Ming‐Yu Yang, Ta‐Chih Liu, Sheng‐Fung Lin, Wei‐Wen Su, Jan‐Gowth Chang	2008	141
3	Abnormal expression of period 1 (PER1) in endometrial carcinoma The Journal of Pathology ·Kun‐Tu Yeh, Ming‐Yu Yang, Ta‐Chih Liu, Jui‐Chang Chen, Wen‐Ling Chan, Sheng‐Fung Lin, Jan‐Gowth Chang	2005	106
4	High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients BMC Cancer ·Wen‐Wei Sung, Yueh‐Min Lin, Pei‐Ru Wu, Hsu‐Heng Yen, Hung‐Wen Lai, Tzu‐Cheng Su, Ren-Hung Huang, Chun-Kai Wen, Chia‐Yu Chen, Chih‐Jung Chen, Kun‐Tu Yeh	2014	98
5	Disturbance of circadian gene expression in breast cancer Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Shou‐Jen Kuo, Shou‐Tung Chen, Kun‐Tu Yeh, Ming‐Feng Hou, Ya‐Sian Chang, Nicholas C. Hsu, Jan‐Gowth Chang	2009	82
6	Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells Cancer Research ·I-Wen Teng, Pei‐Chi Hou, Kuan‐Der Lee, Pei‐Yi Chu, Kun‐Tu Yeh, Victor X. Jin, Min‐Jen Tseng, Shaw‐Jenq Tsai, Yu‐Sun Chang, Chi‐Sheng Wu, H. Sunny Sun, Kuen‐Daw Tsai, Long‐Bin Jeng, Kenneth P. Nephew, Tim H-M. Huang, Shu‐Huei Hsiao, Yu‐Wei Leu	2011	79
7	Promoter methylation in circadian genes of endometrial cancers detected by methylation‐specific PCR Molecular Carcinogenesis ·Mu‐Chin Shih, Kun‐Tu Yeh, Kai‐Ping Tang, Jui‐Chang Chen, Jan‐Gowth Chang	2006	70
8	Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms Environmental Toxicology ·Yen‐Yu Chen, Yuh‐Ming Chang, Kuan‐Yi Wang, Pei‐Ni Chen, You‐Cheng Hseu, Kemin Chen, Kun‐Tu Yeh, Chih‐Jung Chen, Li‐Sung Hsu	2018	67
9	Deregulated expression of circadian clock genes in gastric cancer BMC Gastroenterology ·Ming‐Luen Hu, Kun‐Tu Yeh, Pai‐Mei Lin, Cheng‐Ming Hsu, Hui‐Hua Hsiao, Yi‐Chang Liu, Hugo You‐Hsien Lin, Sheng-Fung Lin, Ming‐Yu Yang	2014	66
10	Significance of somatic mutations and content alteration of mitochondrial DNA in esophageal cancer BMC Cancer ·Duan‐Jun Tan, Julia Chang, Lingling Liu, Renkui Bai, Yu‐Fen Wang, Kun‐Tu Yeh, Lee‐Jun C. Wong	2006	61
11	Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis Acta Histochemica ·Jeng‐Wei Lu, Jan‐Gowth Chang, Kun‐Tu Yeh, Rong-Ming Chen, Jeffrey J. P. Tsai, Rouh‐Mei Hu	2011	59
12	Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma Medical Oncology ·Jeng‐Wei Lu, Yueh‐Min Lin, Jan‐Gowth Chang, Kun‐Tu Yeh, Rong-Ming Chen, Jeffrey Tsai, Wei‐Wen Su, Rouh‐Mei Hu	2013	55
13	The prognostic significance of APC gene mutation and miR‐21 expression in advanced‐stage colorectal cancer Colorectal Disease ·T.‐H. Chen, Su‐Wei Chang, Chao‐Cheng Huang, Kuo‐Lung Wang, Kun‐Tu Yeh, Changbao Liu, H. Lee, Chung‐Chih Lin, Y.‐W. Cheng	2013	54
14	Mitochondrial DNA Content Varies with Pathological Characteristics of Breast Cancer Journal of Oncology ·Renkui Bai, Julia Chang, Kun‐Tu Yeh, Mary Ann Lou, Jyh‐Feng Lu, Duan‐Jun Tan, Hao Liu, Lee‐Jun C. Wong	2011	53
15	Cathepsin B Expression and the Correlation with Clinical Aspects of Oral Squamous Cell Carcinoma PLoS ONE ·Wei‐En Yang, Chuan‐Chen Ho, Shun‐Fa Yang, Shu‐Hui Lin, Kun‐Tu Yeh, Chiao‐Wen Lin, Mu‐Kuan Chen	2016	52
16	Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications Journal of Cancer Research and Clinical Oncology ·H H Tseng, Jan‐Gowth Chang, Yaw‐Huei Hwang, Kun‐Tu Yeh, Yao‐Li Chen, Hsin‐Su Yu	2009	51
17	A recurrent ITGA9 missense mutation in human fetuses with severe chylothorax: possible correlation with poor response to fetal therapy Prenatal Diagnosis ·Gwo‐Chin Ma, Chin‐San Liu, Shun‐Ping Chang, Kun‐Tu Yeh, Yu‐Yuan Ke, Tze-Ho Chen, Boris Bao‐Tyan Wang, Shou‐Jen Kuo, Jin‐Chung Shih, Ming Chen	2008	50
18	Globo-H Ceramide Shed from Cancer Cells Triggers Translin-Associated Factor X-Dependent Angiogenesis Cancer Research ·Jing‐Yan Cheng, Sheng‐Hung Wang, Juway Lin, Yi-Chien Tsai, John Yu, Jen‐Chine Wu, Jung‐Tung Hung, Jin-Jin Lin, Yih-Yiing Wu, Kun‐Tu Yeh, Alice L. Yu	2014	49
19	Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer. PubMed ·Kun‐Tu Yeh, Jan‐Gowth Chang, Ting-Hsu Lin, Yu‐Fen Wang, Ni Tien, Jan‐Yi Chang, Jui‐Chang Chen, Mu‐Chin Shih	2003	47
20	Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer Clinica Chimica Acta ·Shu-Chih Liu, Shun‐Fa Yang, Kun‐Tu Yeh, Chung‐Min Yeh, Hui‐Ling Chiou, Ching-Yi Lee, Ming‐Chih Chou, Yih‐Shou Hsieh	2006	46

About Kun‐Tu Yeh

Kun‐Tu Yeh is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 151 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer-related gene regulation (22 papers), Epigenetics and DNA Methylation (15 papers), RNA modifications and cancer (14 papers), Genetic factors in colorectal cancer (11 papers), Glycosylation and Glycoproteins Research (10 papers), Cancer-related Molecular Pathways (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer-related molecular mechanisms research (9 papers). The work is most often cited by research in Endocrine and Autonomic Systems (689 citations), Aging (160 citations), Cancer Research (751 citations), Molecular Biology (2.0k citations) and Oncology (783 citations). Kun‐Tu Yeh has collaborated with scholars based in Taiwan, United States and Singapore. Frequent co-authors include Jan‐Gowth Chang, Ya‐Sian Chang, Ming‐Feng Hou, Shou‐Jen Kuo, Shou‐Tung Chen, Kong‐Bung Choo, Yueh‐Min Lin, Jui‐Chang Chen, Shu‐Hui Lin and Ming‐Yu Yang. Their work appears in journals such as Clinica Chimica Acta, Medical Oncology, International Journal of Molecular Sciences, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact